Journey Medical Corporation — Cash Flow (NASDAQ:DERM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 2.18 M13.53 M5.24 M9.13 M 3.93 M Cash from investing activities 10 M20 M5 M15 M -94 K Cash from financing activities 53.02 M16.46 M4.8 M16.99 M 21.42 M Free cash flow -7.82 M-6.47 M240 K-5.87 M 3.93 M

News

B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target

Journey Medical Stock: Emrosi Is Winning, But The Stock Hasn't Noticed (NASDAQ:DERM)

Minocycline study shows no microbiome disruption after 16-week use

Journey Medical earnings missed by $0.06, revenue fell short of estimates

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates

Cisco, Flutter, Manulife and more set to report earnings Wednesday

Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates

electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates

OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates

Journey Medical’s Emrosi shows superior efficacy for rosacea

Journey Medical extends $25 million term loan maturity and revises repayment terms